Actin, the great orchestrator C hanges in cell shape or mobility require changes in gene expression. In a new study, Maria Vartiainen, Sebastian Guettler, Banafshe Larijani, and Richard Treisman (Cancer Research UK, London, UK) reveal how actin coordinates both shape and transcription at once.
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Actin rapidly polymerizes into a fi lamentous (F) form in response to cell growth and motility triggers, such as serum stimulation. Serum stimulation also causes a transcription cofactor called MAL to promote transcription from target genes including actin. Reportedly, MAL can bind to monomeric (G) actin. It's possible then that serum-induced polymerization of actin, by lowering the cytoplasmic pool of G actin, frees up transcriptionally active MAL.
Live cell analyses by Vartiainen et al. now reveal that nuclear actin regulates MAL. Fluorescently labeled MAL shuttled back and forth to the nucleus in unstimulated cells, suggesting that G actin binding does not hold MAL in the cytoplasm, as might have been expected. Instead, G actin binding was necessary for rapidly exporting MAL from the nucleus.
Forcing MAL nuclear accumulation (by blocking an export protein) in unstimulated cells was not enough for MALregulated transcription, however. The authors therefore conclude that MAL must also dissociate from G actin to activate its target genes.
Through this feedback mechanism, actin is able to activate its own transcription (and that of actin regulators) when G actin supplies are running low. This ensures constant availability of the cytoskeletal building blocks. According to Treisman, there are several other MAL target genes whose functions in actin dynamics are anything but obvious. The team is now trying to determine how these apparent outsiders fi t in to the scheme. 
Podosomes push through
T o exit the blood, leukocytes must either squeeze past or go directly through the endothelial cells that line the vessels. According to Christopher Carman, Timothy Springer (Harvard Medical School, Boston, MA), and colleagues, to take the latter transcellular route, leukocytes fi rst palpate the endothelial cell with exploratory protrusions called podosomes. The leukocytes then use one, or sometimes several, of these podosomes to push right on through.
The team found that approximately one-third of leukocytes made their way across an in vitro vascular endothelial monolayer by transcellular migration. Carman suggests that, in vivo, at least in some settings, the proportion might be higher. Transcellular migration might even be favored over the paracellular route, as the latter could potentially weaken cell-cell junctions.
To investigate the mechanism of transcellular migration, the team used a combination of live fl uorescence and electron microscopy. Shortly after leukocytes were added to the monolayer, invaginations in the endothelial membranes appeared coincident with the formation of podosomes by the leukocytes.
The leukocytes used these podosomes to prod and poke the endothelial cell until they fi nd a route of least resistance. Organelles other than the nucleus were then pushed out of the way as one large, invasive podosome created a transcellular pore. Leukocytes that were defi cient for an actin regulatory protein called WASP formed podosomes poorly and were thus ineffi cient in forming transcellular pores. Paracellular migration continued as normal, however.
Endothelial cells survived despite this continuous puncturing by migrating leukoctyes. Indeed, multiple leukocytes were able to pass through a single endothelial cell-Carman has spotted up to eight at a time-lending further evidence that this could be the predominant route for transendothelial leukocyte migration in vivo.
